Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 13.49B P/E 74.20 EPS this Y -6.80% Ern Qtrly Grth -
Income -1.27B Forward P/E 3.26 EPS next Y - 50D Avg Chg 6.00%
Sales 17.89B PEG -1.76 EPS past 5Y 1.55% 200D Avg Chg -8.00%
Dividend 4.00% Price/Book 0.68 EPS next 5Y -1.70% 52W High Chg -29.00%
Recommedations 2.50 Quick Ratio 0.51 Shares Outstanding 1.21B 52W Low Chg 18.00%
Insider Own 0.30% ROA 3.19% Shares Float 1.21B Beta 1.37
Inst Own 75.13% ROE -5.84% Shares Shorted/Prior 24.30M/29.80M Price 11.13
Gross Margin 43.33% Profit Margin -7.10% Avg. Volume 11,418,537 Target Price 16.69
Oper. Margin 16.59% Earnings Date May 9 Volume 6,738,246 Change 1.55%

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

VTRS Chatroom

User Image bigwhalealert Posted - 6 hours ago

$VTRS BUY/SELL METER Alert Cross 38% + ๐Ÿš€ https://t8sk.com/VTRS

User Image stockilluminati Posted - 6 hours ago

$VTRS https://www.stockilluminati.com/vtrs/news.php - Wall Street Breakfast: What Moved Markets

User Image hoangkc Posted - 7 hours ago

$VTRS

User Image jy2022 Posted - 1 day ago

$AGRX going and creating a fuckin FDA approved birth control patch is NOT EASY its this and $VTRS Xulane two on the market keep shorting ๐Ÿ˜†๐Ÿ˜†๐Ÿ˜†

User Image jy2022 Posted - 1 day ago

$AGRX these guys have the ONLY other birth control patch aside from Xulane by $VTRS and yโ€™all selling ๐Ÿ˜ญ๐Ÿ˜ญ๐Ÿ˜ญ took 18 years for FDA approval NBD ๐Ÿ˜†๐Ÿ˜†๐Ÿ˜†

User Image Dontbeinadream Posted - 1 day ago

$VTRS At approx 5 percent dividend yield this stock rocks with consistent incremental sales growth every 3 years. Not sure why its falling. But I am adding.

User Image Phizher Posted - 1 day ago

$VTRS should not be under $25. Iโ€™m adding every day until I canโ€™t add anymore. This is absurd. Market missing the mark on this one โ€” market cap is 3B less than 2022 sales and trades at 3x 2023 EARNINGS $Spy $Pfe $mrna

User Image Flybirds Posted - 1 day ago

$AGRX think its a buy out target vor $VTRS

User Image jy2022 Posted - 1 day ago

$AGRX weโ€™re seeing MASSIVE growth here and competitor is $VTRS with a 13B MC granted they have other pharma but we should be at a 100-200M MC imo minimum rn

User Image SweepCast Posted - 1 day ago

@SweepCast Unusual Options Observed: $VTRS with our scanner on $11 CALL Expiring: 01-20-2023 worth 46K๐Ÿ‚ โฌ…๏ธ Use this in real-time with @SweepCast - See Profile for More Info ๐Ÿ†

User Image stockilluminati Posted - 1 day ago

$VTRS https://www.stockilluminati.com/vtrs/news.php - Mittleman Global Value Equity Fund Class P Quarterly Report Q2 2022

User Image stockilluminati Posted - 1 day ago

$VTRS https://www.stockilluminati.com/vtrs/news.php - Tracking Kahn Brothers Portfolio - Q2 2022 Update

User Image Ern_Finkel Posted - 1 day ago

$PSHG highlight . Making money is $GRAB $VTRS $HBAN $MU too, well done ๐Ÿบ

User Image stockilluminati Posted - 2 days ago

$VTRS https://www.stockilluminati.com/vtrs/news.php - Pfizer Is A Solid High-Yielding Idea

User Image STCKPRO Posted - 2 days ago

$VTRS NEW ARTICLE : Pfizer Is A Solid High-Yielding Idea https://www.stck.pro/news/VTRS/32725538

User Image tickeron Posted - 2 days ago

A.I.dvisor made a bullish call on $VTRS, netting in a 6.74% gain over 2 days https://srnk.us/go/3910270

User Image stockilluminati Posted - 2 days ago

$VTRS https://www.stockilluminati.com/vtrs/news.php - Viatris: FX-Related Fears Overblown, Optimizations Bear Fruit

User Image jy2022 Posted - 2 days ago

$AGRX so youโ€™re telling me $VTRS our ONLY other competitor has a 13 BILLION MARKET CAP at $10 per share and weโ€™re at 25 MILLION MARKET CAP?!?! FUCKKKKK OFFF MM AND STUPID SHORTS Key Points: -Same manufacturer as Crest Whitestrips -Tutes Unexecuted Warrants priced .90-$10.40 - SEC Filing stating enough Liquidity til 2023 and No Bankruptcy or Reorganization in next 12 months - Offering Complete EASY $10+ STOCK ๐Ÿ’Ž๐Ÿ™Œ๐Ÿผ

User Image _axe_capital_ Posted - 2 days ago

$VTRS boom hit $10.5+ ๐Ÿ“ˆ

User Image jy2022 Posted - 2 days ago

$AGRX CEO spent 18 years on this product and getting FDA approval to top it all off he sold his last company at $4.15 per share and twirla has got only ONE COMPETITOR IN THE PATCH SPACE AND THAT IS XULANE BY $VTRS $ENDP $EVFM

User Image jy2022 Posted - 2 days ago

$AGRX thereโ€™s only TWO FDA APPROVED BIRTH CONTROL PATCHES IN ENTIRE WORLD THIS AND XULANE BY MYLAN WHICH WAS BOUGHT BY $VTRS $EVFM $ENDP

User Image SweepCast Posted - 3 days ago

@SweepCast Unusual Options Observed: $VTRS with our scanner on $12 CALL Expiring: 03-17-2023 worth 240K๐Ÿ‚ โฌ…๏ธ SweepCast lets you catch the action in real time. - See Profile for More Info ๐Ÿ†

User Image TwoThreeFourFiveSix Posted - 3 days ago

$VTRS coming up to real resistance, multiple vwap deviations above.

User Image BidaskBot Posted - 3 days ago

Viatris $VTRS BidaskScore is Upgraded to Held https://bidaskclub.com/news/company/2022-08-09/VTRS

User Image SweepCast Posted - 3 days ago

@SweepCast Unusual Options Observed: $VTRS with our scanner on $12.5 PUT Expiring: 01-20-2023 worth 119K๐Ÿป โฌ…๏ธ SweepCast lets you catch the action in real time. - See Profile for More Info ๐Ÿ†

User Image Project_ALGO Posted - 3 days ago

Highest Inflow Names Today (Large Cap) $ITUB - 90% Bullish $BAC - 93% Bullish $GOLD - 98% Bullish $VTRS - 94% Bullish $FE - 90% Bullish Ranked By Volume ๐Ÿ“ˆ

User Image PippIpofCfvi Posted - 4 days ago

$VTRS Does it has any product about monkeypox?

User Image Stockbeep_Scanner Posted - 4 days ago

Breakouts in the PM $FAZE $VTRS $RPRX stockbeep.com/bopmaug9

User Image Jiricek94 Posted - 4 days ago

$VTRS atleast something is up today :D

User Image SparkNewswire Posted - 4 days ago

$VTRS BMO Capital Maintains Outperform on Viatris, Lowers Price Target to $16 https://t.co/NdgmANV9fe

Analyst Ratings
Piper Sandler Neutral Mar 16, 22
Citigroup Neutral Mar 10, 22
B of A Securities Neutral Mar 1, 22
Raymond James Market Perform Mar 1, 22
Citigroup Neutral Jun 15, 21
Morgan Stanley Equal-Weight Mar 10, 21
Goldman Sachs Neutral Mar 8, 21
JP Morgan Neutral Mar 2, 21
Raymond James Outperform Feb 23, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Taddese Menassie See Remarks See Remarks May 27 Sell 12.0737 8,813 106,406 05/27/22
READ IAN C Director Director Mar 21 Option 0.00 166 14,497 03/23/22
PARRISH MARK W Director Director Mar 21 Option 0.00 166 82,250 03/23/22
MARK RICHARD A Director Director Mar 21 Option 0.00 166 33,165 03/23/22
Lyons Dillon JoEllen Director Director Mar 21 Option 0.00 166 39,546 03/23/22
DIMICK NEIL F Director Director Mar 21 Option 0.00 166 75,200 03/23/22
KORMAN HARRY Director Director Mar 21 Option 0.00 166 50,638 03/23/22
KILTS JAMES M Director Director Mar 21 Option 0.00 166 79,402 03/23/22
HIGGINS MELINA E Director Director Mar 21 Option 0.00 166 63,068 03/23/22
CORNWELL W DON Director Director Mar 21 Option 0.00 166 22,197 03/23/22
CORNWELL W DON Director Director Mar 15 Buy 9.8968 2,700 26,721 22,031 03/15/22
GOETTLER MICHAEL Chief Executive Offi.. Chief Executive Officer Mar 15 Buy 9.866 50,352 496,773 136,796 03/15/22
COURY ROBERT J Executive Chairman Executive Chairman Mar 09 Sell 10.17 500,000 5,085,000 03/11/22